Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve the care of patients with cutaneous ...

Unravelling melanoma brain metastasis tumor microenvironment characteristics using spatial transcriptomics [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting ...

Distinct CD8+T cell subsets in advanced melanoma patients with liver metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular ...

stage IIB-IV melanoma who have had surgical resection to remove the tumour. The primary endpoint is recurrence-free survival, with overall survival and metastasis-free survival as secondary endpoints.

Secondary endpoints include overall survival (OS), distant metastasis-free survival (DMFS), lung cancer-specific ... for skin cancer melanoma, once again as an adjuvant therapy, in patients ...

In summary, Zero-Stage Lung Cancer is highly treatable when caught early Veteran actress Sharmila Tagore recently shared a deeply personal revelation that she had battled cancer. The news took ...

A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology. Abstract 853: ...

Metastasis causes most cancer deaths, yet this process remains one of the most enigmatic aspects of the disease. Building on new mechanistic insights emerging from recent research, we offer our ...

They discovered that these hyperconnected 3D hubs appear to be a feature of most cancers, including melanoma, lung, prostate, uterine and others. Although each cancer has a unique set of hubs ...

Early diagnosis of lung cancer may improve the prognosis, but many people aren’t aware they have it until it spreads. Screening tests may help detect the disease. Blood tests are not yet ...

The market for osteosarcoma treatments was estimated at $1.2 billion in 2022, with a significant portion of patients developing lung metastasis after initial treatment. The company believes OST ...

Patients with lung cancer, breast cancer ... thyroid cancer, lymphoma, melanoma, and gastrointestinal malignancies. Favorable response to treatment directly correlates with early recognition ...